Wall Street Analysts See a 108.23% Upside in Lexeo Therapeutics, Inc. (LXEO): Can the Stock Really Move This High?

Lexeo Therapeutics, Inc. (LXEO) closed the last trading session at $9.23, gaining 41.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $19.22 indicates a 108.2% upside potential.The average comprises nine short-term price targets ranging from a low of $9.00 to a high of $30.00, with a standard deviation of $6.57. While the lowest estimate indicates a decline of 2.5% from the curre ...